Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-29

Clinical Trial Update: ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a Type 2 diabetes mellitus study sponsored by AstraZeneca; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2019-08-29